Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin [13]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 4, 2007, Pages 553-554

  Korber A ^a   Franckson, T ^a   Grabbe, S ^a   Dissemond, J ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN 7S; IMMUNOGLOBULIN LAMBDA CHAIN; INTERFERON; MELPHALAN; UNCLASSIFIED DRUG; VENIMMUN N;

AGED; ARM MOVEMENT; CASE REPORT; COMORBIDITY; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; JAW MOVEMENT; LETTER; LOW DRUG DOSE; MONOCLONAL IMMUNOGLOBULINEMIA; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PUVA; SCLEROMYXEDEMA; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; PARAPROTEINEMIAS; SCLEROMYXEDEMA; TREATMENT OUTCOME;

EID: 33947403867     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01951.x     Document Type: Letter

References (8)

1. Knezevic-Maramica I, Kruskall MS. Intravenous immune globulins: An update for clinicians. Transfusion 2003; 43: 1460-1480.
2. Dinneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995; 33: 37-43.
3. Lang E, Zabel M, Schmidt H. Arndt-Gottron scleromyxedema and associated phenomena. Dermatologica 1984; 169: 29-35.
4. Wallington T. New uses for IVIgG immunoglobulin therapies. Vox Sang 2004; 87: 155-157.
5. Karim A, Lawlor F, Black MM. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin. Clin Exp Dermatol 2004; 29: 317-318.
6. Righi A, Schiavon F, Jablonska S et al. Intravenous immunoglobulins control scleromyxoedema. Ann Rheum Dis 2002; 61: 59-61.
7. Kulczycki A, Nelson M, Eisen A, Heffernan M. Scleromyxoedema: Treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Br J Dermatol 2003; 149: 1276-1281.
8. Lister RK, Jolles S, Whittaker S et al. Scleromyxedema: Response to high dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 2000; 43: 403-408.